Edition:
United Kingdom

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

683.25INR
12 Dec 2017
Change (% chg)

Rs0.40 (+0.06%)
Prev Close
Rs682.85
Open
Rs685.95
Day's High
Rs694.00
Day's Low
Rs676.10
Volume
266,047
Avg. Vol
324,761
52-wk High
Rs878.00
52-wk Low
Rs555.00

Latest Key Developments (Source: Significant Developments)

Jubilant Life Sciences Says Co Not Got Formal Environmental Nod For Gujarat Pesticide Project
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Jubilant Life Sciences Ltd ::CLARIFIES ON NEWS ITEM ON CO'S PESTICIDE PROJECT IN GUJARAT GETTING GREEN PANEL NOD.SAYS CO HAS NOT GOT ANY FORMAL ENVIRONMENTAL NOD FOR GUJARAT PESTICIDE PROJECT.  Full Article

Jubilant Life Sciences says received ANDA approval for Indomethacin capsules USP
Monday, 28 Aug 2017 

Aug 28 (Reuters) - Jubilant Life Sciences Ltd ::Says Jubilant receives ANDA approval for Indomethacin capsules USP.Says drug is a nonsteroidal anti-inflammatory drug used for treatment of moderate to severe inflammation and reduce pain.  Full Article

Jubilant Life Sciences gets FDA nod for generic version of Crestor drug
Tuesday, 1 Nov 2016 

Jubilant Life Sciences Ltd :Says Jubilant Life Sciences receives ANDA approval for rosuvastatin calcium tablets.  Full Article

Jubilant Life Sciences gets ANDA approval for Darifenacin ER tablets
Thursday, 13 Oct 2016 

Jubilant Life Sciences Ltd :Says Jubilant Life Sciences receives ANDA approval for Darifenacin ER tablets.  Full Article

Jubilant Life Sciences gets Australian approval for Lyophilized kit
Wednesday, 5 Oct 2016 

Jubilant Life Sciences Ltd :Says Jubilant receives Australian approval for Lyophilized kit for the preparation of Tc 99m MAA injection.  Full Article

Jubilant Life Sciences says unit to issue high yield bonds outside India
Friday, 23 Sep 2016 

Jubilant Life Sciences Ltd : Approved the proposal to launch a benchmark offering of unsecured high yield bonds outside India by JPL .The notes are proposed to be listed on the Singapore Exchange Securities Trading Limited.  Full Article

Jubilant Life Sciences gets ANDA approval for felodipine ER tablets
Thursday, 25 Aug 2016 

Jubilant Life Sciences Ltd : Jubilant Life Sciences receives ANDA approval for Felodipine ER tablets .  Full Article

Jubilant Life Sciences gets ANDA approval for telmisartan tablets
Wednesday, 24 Aug 2016 

Jubilant LifeSciences Ltd : Jubilant Life Sciences receives ANDA approval for telmisartan tablets .  Full Article

Jubilant Life Sciences June-qtr consol profit up about 23 pct
Tuesday, 9 Aug 2016 

Jubilant Life Sciences Ltd : June-quarter consol net profit 1.62 billion rupees; consol net sales 14.01 billion rupees . Consol net profit in June quarter last year was 1.32 billion rupees as per Ind-AS; consol net sales was 14.26 billion rupees . Further company coverage [JULS.NS] ((Bangalore.newsroom@thomsonreuters.com)).  Full Article

Jubilant Biosys enters into out-licensing agreement with Checkpoint Therapeutics for Novel BET inhibitors
Friday, 27 May 2016 

Jubilant Life Sciences Ltd : Enters into exclusive out licensing agreement with Checkpoint Therapeutics for novel bet inhibitors . Co, Checkpoint Therapeutics sign worldwide license agreement . Jubilant Biosys will out-license to checkpoint a family of patents covering compounds that inhibit brd4 .Deal includes up-front payment of $2 million, contingent preclinical, clinical, regulatory payments.  Full Article